Publication | Closed Access

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patients

Treatment And PreventionNeurovirologyMedicineAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyHuman Immunodeficiency Virus—Antimicrobial PharmacokineticsAntiviral DrugHivPharmacologyGanciclovir Absolute BioavailabilityPharmacodynamic ModelingSteady-state Pharmacokinetics